The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Porcine Vaccines-Global Market Insights and Sales Trends 2024

Porcine Vaccines-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1838330

No of Pages : 118

Ask Your Query
Synopsis
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The global Porcine Vaccines market size is expected to reach US$ 2099.7 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029. The market is mainly driven by the significant applications of Porcine Vaccines in various end use industries. The expanding demands from the Government Tender and Market Sales, are propelling Porcine Vaccines market. CSF Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the FMD Vaccines segment is estimated at % CAGR for the next seven-year period.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Porcine Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Porcine Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Porcine Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Porcine Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Porcine Vaccines covered in this report include Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio and Chopper Biology, etc.
The global Porcine Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
DHN
CAVAC
Virbac
HVRI
Bioveta
Global Porcine Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Porcine Vaccines market, Segment by Type:
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Other
Global Porcine Vaccines market, by Application
Government Tender
Market Sales
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Porcine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Porcine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Porcine Vaccines Market Overview
1.1 Porcine Vaccines Product Overview
1.2 Porcine Vaccines Market Segment by Type
1.2.1 CSF Vaccines
1.2.2 FMD Vaccines
1.2.3 Porcine Circovirus Vaccines
1.2.4 PRRS Vaccines
1.2.5 Other
1.3 Global Porcine Vaccines Market Size by Type
1.3.1 Global Porcine Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Porcine Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Porcine Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Porcine Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Porcine Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Porcine Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Porcine Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Porcine Vaccines Sales Breakdown by Type (2018-2023)
2 Global Porcine Vaccines Market Competition by Company
2.1 Global Top Players by Porcine Vaccines Sales (2018-2023)
2.2 Global Top Players by Porcine Vaccines Revenue (2018-2023)
2.3 Global Top Players by Porcine Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Porcine Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Porcine Vaccines Market Competitive Situation and Trends
2.5.1 Porcine Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Porcine Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Porcine Vaccines Market
2.8 Key Manufacturers Porcine Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Porcine Vaccines Status and Outlook by Region
3.1 Global Porcine Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Porcine Vaccines Historic Market Size by Region
3.2.1 Global Porcine Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Porcine Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Porcine Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Porcine Vaccines Forecasted Market Size by Region
3.3.1 Global Porcine Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Porcine Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Porcine Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Porcine Vaccines by Application
4.1 Porcine Vaccines Market Segment by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Porcine Vaccines Market Size by Application
4.2.1 Global Porcine Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Porcine Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Porcine Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Porcine Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Porcine Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Porcine Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Porcine Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Porcine Vaccines Sales Breakdown by Application (2018-2023)
5 North America Porcine Vaccines by Country
5.1 North America Porcine Vaccines Historic Market Size by Country
5.1.1 North America Porcine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Porcine Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Porcine Vaccines Sales in Value by Country (2018-2023)
5.2 North America Porcine Vaccines Forecasted Market Size by Country
5.2.1 North America Porcine Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Porcine Vaccines Sales in Value by Country (2024-2029)
6 Europe Porcine Vaccines by Country
6.1 Europe Porcine Vaccines Historic Market Size by Country
6.1.1 Europe Porcine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Porcine Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Porcine Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Porcine Vaccines Forecasted Market Size by Country
6.2.1 Europe Porcine Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Porcine Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Porcine Vaccines by Region
7.1 Asia-Pacific Porcine Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Porcine Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Porcine Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Porcine Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Porcine Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Porcine Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Porcine Vaccines Sales in Value by Region (2024-2029)
8 Latin America Porcine Vaccines by Country
8.1 Latin America Porcine Vaccines Historic Market Size by Country
8.1.1 Latin America Porcine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Porcine Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Porcine Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Porcine Vaccines Forecasted Market Size by Country
8.2.1 Latin America Porcine Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Porcine Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Porcine Vaccines by Country
9.1 Middle East and Africa Porcine Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Porcine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Porcine Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Porcine Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Porcine Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Porcine Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Porcine Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Porcine Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Porcine Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Jinyu Bio-Technology
10.3.1 Jinyu Bio-Technology Company Information
10.3.2 Jinyu Bio-Technology Introduction and Business Overview
10.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Jinyu Bio-Technology Porcine Vaccines Products Offered
10.3.5 Jinyu Bio-Technology Recent Development
10.4 CAHIC
10.4.1 CAHIC Company Information
10.4.2 CAHIC Introduction and Business Overview
10.4.3 CAHIC Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CAHIC Porcine Vaccines Products Offered
10.4.5 CAHIC Recent Development
10.5 Tecon
10.5.1 Tecon Company Information
10.5.2 Tecon Introduction and Business Overview
10.5.3 Tecon Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tecon Porcine Vaccines Products Offered
10.5.5 Tecon Recent Development
10.6 Zoetis
10.6.1 Zoetis Company Information
10.6.2 Zoetis Introduction and Business Overview
10.6.3 Zoetis Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Zoetis Porcine Vaccines Products Offered
10.6.5 Zoetis Recent Development
10.7 Ceva
10.7.1 Ceva Company Information
10.7.2 Ceva Introduction and Business Overview
10.7.3 Ceva Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ceva Porcine Vaccines Products Offered
10.7.5 Ceva Recent Development
10.8 Hile Bio
10.8.1 Hile Bio Company Information
10.8.2 Hile Bio Introduction and Business Overview
10.8.3 Hile Bio Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hile Bio Porcine Vaccines Products Offered
10.8.5 Hile Bio Recent Development
10.9 Chopper Biology
10.9.1 Chopper Biology Company Information
10.9.2 Chopper Biology Introduction and Business Overview
10.9.3 Chopper Biology Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Chopper Biology Porcine Vaccines Products Offered
10.9.5 Chopper Biology Recent Development
10.10 WINSUN
10.10.1 WINSUN Company Information
10.10.2 WINSUN Introduction and Business Overview
10.10.3 WINSUN Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 WINSUN Porcine Vaccines Products Offered
10.10.5 WINSUN Recent Development
10.11 Hipra
10.11.1 Hipra Company Information
10.11.2 Hipra Introduction and Business Overview
10.11.3 Hipra Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hipra Porcine Vaccines Products Offered
10.11.5 Hipra Recent Development
10.12 Ringpu Biology
10.12.1 Ringpu Biology Company Information
10.12.2 Ringpu Biology Introduction and Business Overview
10.12.3 Ringpu Biology Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Ringpu Biology Porcine Vaccines Products Offered
10.12.5 Ringpu Biology Recent Development
10.13 DHN
10.13.1 DHN Company Information
10.13.2 DHN Introduction and Business Overview
10.13.3 DHN Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 DHN Porcine Vaccines Products Offered
10.13.5 DHN Recent Development
10.14 CAVAC
10.14.1 CAVAC Company Information
10.14.2 CAVAC Introduction and Business Overview
10.14.3 CAVAC Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 CAVAC Porcine Vaccines Products Offered
10.14.5 CAVAC Recent Development
10.15 Virbac
10.15.1 Virbac Company Information
10.15.2 Virbac Introduction and Business Overview
10.15.3 Virbac Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Virbac Porcine Vaccines Products Offered
10.15.5 Virbac Recent Development
10.16 HVRI
10.16.1 HVRI Company Information
10.16.2 HVRI Introduction and Business Overview
10.16.3 HVRI Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 HVRI Porcine Vaccines Products Offered
10.16.5 HVRI Recent Development
10.17 Bioveta
10.17.1 Bioveta Company Information
10.17.2 Bioveta Introduction and Business Overview
10.17.3 Bioveta Porcine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Bioveta Porcine Vaccines Products Offered
10.17.5 Bioveta Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Porcine Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Porcine Vaccines Industrial Chain Analysis
11.4 Porcine Vaccines Market Dynamics
11.4.1 Porcine Vaccines Industry Trends
11.4.2 Porcine Vaccines Market Drivers
11.4.3 Porcine Vaccines Market Challenges
11.4.4 Porcine Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Porcine Vaccines Distributors
12.3 Porcine Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock